|
|
|
|
| LEADER |
00811nas a22002292 4500 |
| 001 |
ebs9432230e |
| 003 |
EBZ |
| 006 |
m d |||||| |
| 007 |
cr|unu|||||||| |
| 008 |
200707| xx uu p s 0 0eng d |
| 022 |
|
|
|y 0929-1903
|
| 035 |
|
|
|a (EBZ)ebs9432230e
|
| 040 |
|
|
|a EBZ
|
| 042 |
|
|
|a msc
|
| 130 |
0 |
|
|a Cancer gene therapy [Cancer Gene Ther] NLMUID: 9432230 (Online)
|
| 222 |
1 |
0 |
|a Cancer gene therapy [Cancer Gene Ther] NLMUID: 9432230
|
| 245 |
0 |
0 |
|a Cancer gene therapy [Cancer Gene Ther] NLMUID: 9432230
|h [electronic resource].
|
| 773 |
0 |
|
|t MEDLINE with Full Text
|d EBSCO
|
| 856 |
4 |
0 |
|3 Full text available: Jan 1999-Nov 2015.
|z Available in MEDLINE with Full Text.
|u https://search.ebscohost.com/direct.asp?db=mnh&jid=%229432230%22&scope=site
|
| 999 |
|
|
|c 135661
|d 135661
|
| 942 |
|
|
|z EBS
|
| 942 |
|
|
|c REL
|